XML 23 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Cash flows from operating activities:    
Net loss $ (16,240) $ (15,292)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 322 1,933
Warrant liability revaluation income (4,920) (11,884)
Derivative liability revaluation expense 1,407 462
Loss on disposal or impairment of property and equipment 40 69
Depreciation and amortization 384 564
Amortization of discount on convertible debt converted to common shares 86 0
Intangible asset impairment 0 3,905
Recovery of doubtful accounts 0 (12)
Loss on write-down of inventory 0 356
Decrease (increase) in operating assets:    
Accounts receivable 0 12
Inventory 0 126
Prepaid expenses and other current assets 28 796
Other assets 26 (65)
Increase (decrease) in operating liabilities:    
Accounts payable 69 (139)
Related party payable 1,361 (9,778)
Accrued expenses and deferred rent (342) (214)
Accrued interest payable 742 228
Deferred revenue 0 (457)
Net cash used in operating activities (17,037) (29,390)
Cash flows from investing activities:    
Purchase of property and equipment (433) (253)
Proceeds from the sale of property and equipment 0 1
Net cash used in investing activities (433) (252)
Cash flows from financing activities:    
Proceeds from private placement, net 7,623 17,933
Proceeds from common stock offering, net 9,749 0
Payment of deferred offering costs 0 (42)
Principal payments on capital lease obligations 0 (2)
Net cash provided by financing activities 17,372 17,889
Net decrease in cash and cash equivalents (98) (11,753)
Cash and cash equivalents, beginning of period 17,515 29,268
Cash and cash equivalents, end of period 17,417 17,515
Noncash Investing and Financing Items [Abstract]    
Property and equipment in accounts payable 29 57
Offering costs in accounts payable and accrued expenses 444 23
Reduction of warrant liability upon cashless exercise of warrants 41 0
Reduction of accrued interest payable upon cashless exercise of promissory notes 3 0
Reduction in derivative liability upon cashless exercise of promissory notes 6 0
Cashless exercise of promissory notes 85 0
Dividend paid in-kind to preferred stockholders 264 0
Deemed dividend on preferred stock $ 4,099 $ 0